Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
83 results about "Cns injury" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Injury to the CNS, which consists of the brain and spinal cord, are major international health problems. 2.5 million people in the U.S. suffer traumatic brain injuries annually, and about 800,000 people per year suffer from stroke.
Multifunctional composite rehabilitation system for patient suffering from central nerve injury
ActiveCN102813998ARealize human-machine coordinated controlGood curative effectGymnastic exercisingChiropractic devicesDiseaseHuman motion
The invention discloses a multifunctional composite rehabilitation system for a patient suffering from central nerve injury. The multifunctional composite rehabilitation system comprises a database module, a data managing module, a man-machine interaction module, a function evaluating module, a prescription generating and managing module, a calculating module, a system control module and a safety protecting module. By utilizing the artificial intelligence, the human motion intension can be predicted and recognized, the man-machine coordination control is realized, and the active type rehabilitation treatment of the patient is finished; through a multisource signal collection, signal fusion and real-time control technologies, every function is organically combined, the coordinative rehabilitation treatment of every function module is realized, the rehabilitation effect is effectively improved and the labor consumption is reduced; during the process of rehabilitation, the patient is guided to finish the rehabilitation treatment step by step by using the virtual reality technology; through the interaction among a doctor, the patient and a computer, a progressive composite rehabilitation strategy according with the disease condition of the patient is comprehensively determined, so that the patient suffering fromnerve injury can receive the most effective rehabilitation treatment within a gold rehabilitation period of 50 days, and therefore, the maximization of the functional rehabilitation is promoted.
Owner:SHANGHAI JIAO TONG UNIV
Methods for the treatment of a traumatic central nervous system injury via a tapered administration protocol
InactiveUS20090221544A1Preventing neuronal damagePrevent exitOrganic active ingredientsNervous disorderDrugCns injury
The present invention provides methods for the treatment or the prevention of neuronal damage in the CNS. Specifically, the methods of the invention provide for the administration of a therapeutically effective amount of a progestin or progestin metabolite following a traumatic or ischemic injury to the CNS such that, prior to termination of administration of the progestin or progestin metabolite the administration is tapered to avoid withdrawal. The drug taper employed can involve a linear taper, an exponential taper, progressively dividing administered doses by 50%, or can be determined based on the treating physician's assessment of the patient's response to therapy. The tapered administration methods of the present invention may be used in combination with any therapeutic protocol or regimen for the administration of a therapeutically effective amount of a progestin or progestin metabolite to treat a traumatic or ischemic CNS injury.
Owner:EMORY UNIVERSITY
Methods and compositions for treating a subject for central nervous system (CNS) injury
ActiveUS20110224278A1Altered turnoverImprove plasticityBiocideNervous disorderGamma-Aminobutyric acidMedicine
Methods for treating a central nervous system (CNS) injury in a subject are provided. Aspects of the methods include administering to the subject an effective amount of gamma aminobutyric acid (GABA) receptor signaling inhibitor to treat the subject for the CNS injury. Also provided are compositions finding use in embodiments of the methods. Methods and compositions of the invention find use in the treatment of a variety of different CNS injuries, including but not limited to, treating a subject for CNS injury associated with the occurrence of stroke.
Owner:RGT UNIV OF CALIFORNIA
Neural scaffolds
Disclosed herein are compositions and methods useful for preparing neural scaffolds. The scaffolds comprise tissue taken from the spinal cord and / or dura mater of vertebrate and can be processed to form gels or sheets. Methods of treating patient with CNS injury are also presented.
Owner:UNIVERSITY OF PITTSBURGH
Methods, compositions and kits for promoting recovery from damage to the central nervous system
InactiveUS6749850B1Promote recoveryImprove abilitiesBiocideNervous disorderSensation movementStimulant
The present application relates to methods, kits and compositions for improving a subject's recovery from CNS injury. In certain aspects, methods of the invention comprise administering to a subject cells and a neural stimulant. Recovery may be manifest by improvements in sensorimotor or cognitive abilities, e.g., improved limb movement and control or improved speech capability. In certain embodiments, subject methods can be used as part of a treatment for damage resulting from ischemia, hypoxia or trauma.
Owner:CHILDRENS MEDICAL CENT CORP +1
Combination of huperzine and nicotinic compounds as a neuroprotective agent
InactiveUS6369052B1Enhance memoryPrevent and reverse memory declineBiocideNervous disorderRisk strokeDisease cause
The present invention provides compositions and methods for treating, preventing, or reversing neuronal dysfunction including cognitive decline, such as cognitive decline associated with aging and minimal cognitive impairment; severe neurodegenerative disorders, such as Alzheimer's disease; and neuronal dysfunction associated with loss of motor skills, such as Parkinson's disease and amyotrophic lateral sclerosis. The compositions and methods of the invention can also treat or prevent neuronal dysfunction resulting from CNS injury, such as stroke, spinal-cord injury, and peripheral-nerve injury. The compositions of the invention comprises a huperzine compound and a nicotinic compound.
Owner:GEORGETOWN UNIV
Slave-type lower limb gait training rehabilitation robot system
PendingCN109568089ASolve the problem that it is difficult to maintain the balance of usersAvoid secondary damageWalking aidsExoskeleton robotEngineering
The invention discloses a slave-type lower limb gait training rehabilitation robot system which is divided into a lower limb wearable exoskeleton robot and a slave robot. The slave-type lower limb gait training rehabilitation robot system comprises two translational degrees of freedom, two vertical weight loss degrees of freedom of the slave robot and six rotational degrees of freedom of two legs,hip and knee of the wearable robot. The lower limb wearable exoskeleton robot is fixed on lower limbs and waist of a patient and provides walking assistance according to the gait of the patient and helps the patient to complete the walking action; and the slave robot is connected with the lower limb wearable exoskeleton robot to play a role in supporting the patient and reducing the weight, so that the corresponding following movement can be realized according to the walking of the patient. The slave-type lower limb gait training rehabilitation robot system is mainly used for solving variouslower limb movement dysfunctions caused by the central nerve injury, provides the safe, long-acting and large-range gait training for the patient and can improve the lower limb rehabilitation trainingefficiency of the patient.
Owner:UNIV OF SCI & TECH OF CHINA
Ginseng saponin Rg1 and Rb1 in pseudo-ginseng and preparation of total saponin thereof
The invention belongs to the medicine technical filed, in particular to a preparation method of monomeric compound ginsenoside Rg1, ginsenoside Rb1 and total arasaponin and the application in the medicine field thereof. The fresh medicinal material, the dried medicinal material and the medicinal material on the market of Panax notoginseng are taken as the raw materials; according to the polarity and the solubility property of a compound, separation and purification are carried out by adopting the solvent extraction method, the crystallization process and the chromatography and total arasaponin powder is prepared by combining the common drying means, such as decompression concentration drying, freeze drying, vacuum drying and the like; by carrying out one or more methods of recrystal, normal phase, opposite phase silica gel column chromatography, daiamid column chromatography and sephadex chromatography and the like on the powder, the ginsenoside Rg1 and the ginsenoside Rb1 monomers are prepared. The medicines which take the ginsenoside Rg1 and the ginsenoside Rb1 monomers or the total arasaponin as the active ingredients can be used for preventing and / or curing the senile dementia, the neurodegenerative diseases, the cerebrovascular disorder, various dysmnesia, the central lesion and other diseases.
Owner:YUNNAN JECUI BIOTECH
NGF-Fc fusion protein and preparation method thereof
InactiveCN105273087AImprove stabilityExtended half-lifeNervous disorderPeptide/protein ingredientsDiseaseNervous system
The invention belongs to the technical field of biological engineering, and relates to an NGF-Fc fusion protein and a preparation method thereof. The method comprises the following steps: constructing a human immune globulin IgG Fc and nerve growth factor (NGF) fusion gene expression vector through a genetic engineering means, transferring to a mammal cell to make the transferred mammal cell highly express and produce NGF-Fc fusion proteins, purifying, identifying and carrying out biological activity detection. The expression vector transferred mammal cell constructed in the invention can express bioactive NGF-Fc fusion proteins, so the expression level can be 150mg / L or above, and the obtained protein has good stability and long half life, and can be used to prepare drugs for treating Alzheimer's disease, diabetic peripheral neuropathy, Parkinson's disease, facial neuritis, craniocerebral trauma, trauma of spinal cord, acute cerebrovascular disease, encephalatrophy and other neurological diseases, and peripheral nerve injury acute cerebral vascular central nerve injuries induced by chemical drugs.
Owner:FUDAN UNIV
Nogo-A receptor binding peptide as well as derivative and application thereof
ActiveCN105061560AInhibit bindingPromote regenerationNervous disorderPeptide/protein ingredientsProtein detectionAmino acid side chain
The invention belongs to the field of biological medicine, and particularly relates to a Nogo-A receptor binding peptide as well as a derivative and an application thereof. The amino acid residue sequence of the Nogo-A receptor binding peptide is HIYTALV or GFATITG. The derivative of the binding peptide is a product obtained through conventional modification of an amino terminal or a carboxyl terminal of a Nogo-A receptor binding peptide fragment on a Nogo-A receptor binding peptide amino acid side chain group or a product obtained by connecting a label used for peptide or protein detection or purification on the Nogo-A receptor binding peptide. The binding peptide and the derivative of the binding peptide can be bound with NgR in vitro, nerve regeneration is promoted by preventing binding of NgR and Nogo-A, nerve regeneration barriers caused by central nervous injury diseases can be treated, recovery of a central nervous function is promoted, and the binding peptide and the derivative can be widely applied in the medical and biological fields.
Owner:JINAN UNIVERSITY
Analysis method for neuron injury related differentially expressed protein
ActiveCN105467022AEffective and accurateGood precisionComponent separationMaterial analysis by electric/magnetic meansTotal proteinDrug treatment
The present invention relates to an analysis method for a neuron injury related differentially expressed protein. The method comprises: 1, constructing a zebrafish brain and central nerve injury model, and grouping; 2, carrying out drug treatment on the drug group; 3, extracting the total protein in each group; 4, loading the sample onto a mass spectrometer, and analyzing; and 5, carrying out bioinformatics analysis.
Owner:TIANJIN TASLY MORDEN TCM RESOURCES
Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
InactiveUS7202279B1Strong central nervous system （CNS） activityImprove cognitive functionBiocideNervous disorderDiseaseMedicine
The present invention provides 4-substituted-2-azetidinone compounds, bicyclic 2-5-diketopiperazine compounds, and pharmaceutical compositions thereof that are potent, safe and effective neuroprotective agents. Due to their strong central nervous system (CNS) activity, the compounds can be used to enhance memory and to treat a variety of neurological disorders. The compounds are particularly useful for treating neurological disorders caused by, or associated with, CNS trauma.
Owner:GEORGETOWN UNIV
Achyranthes bidentata polypeptide, preparing process and uses
InactiveCN101270147APromote growthInhibit apoptosisNervous disorderPeptide/protein ingredientsDiseaseMedicinal herbs
The present invention discloses achyranthes bidentata polypeptide, a production method and applications, and the achyranthes bidentata polypeptide is produced with the steps including polypeptide extraction, polypeptide separation, etc. The achyranthes bidentata polypeptide is used to the preparation of drugs and health products for treating peripheral nerve injuries, cerebrovascular accidents, ischemic brain injuries, cerebral traumas, optic nerve injuries, spinal cord injuries and central nervous system injuries, antiaging and preventing neurodegenerative diseases. Experiments prove that the extracted achyranthes bidentata polypeptide (protein) of the present invention has the effects of promoting the growth of nerves, preventing the fading of nerve cells and promoting the regeneration of injured nerves, the source of medicinal materials is single, the preparation method is advanced, the technique is reasonable, the ingredients of preparations are definite, safety is high, and pharmacological action is obvious.
Owner:NANTONG UNIVERSITY
Neurotherapeutic Nanoparticle Compositions and Devices
There are provided compositions and methods for treatment of neurodegeneative diseases and CNS injury. The compositions a pharmaceutically acceptable carrier solution; and a plurality of biodegradable nanoparticles, wherein the nanoparticles comprise a targeting moiety that is able to bind selectively to the surface of a neural stem cell and wherein the nanoparticles further comprise factors such as leukaemia inhibitory factor (LIF); XAV939 and / or one or more of : brain-derived neurotrophic factor (BDNF) or an agonist thereof; epidermal growth factor (EGF) or an agonist thereof; glial cell-derived neurotrophic factor (GDNF) or an agonist thereof; retinoic acid and derivatives thereof; ciliary neurotrophic factor (CTNF) or an agonist thereof; and Wnt5A. The biodegradable nanoparticles may deliver via controlled time release.
Owner:YALE UNIV
Protein biomarkers for acute, subacute and chronic traumatic injuries of the central nervous system
Proteins that are differentially expressed or elevated in tissue and biofluids after central nervous system injuries are described. Elevated or reduced levels of the proteins, alone or in various combinations or ratios, can be used to assess severity of central nervous system injury (CNS injury) including traumatic brain injury (TBI), traumatic spinal cord injury (SCI) and chronic traumatic encephalopathy (CTE). Time course measurements post CNS-injury of these proteins can be used to monitor progress or recovery over periods up to several months. Differentiation of acute, subacute and chronic injury can be diagnosed by comparing the protein levels in CNS-injury patients at days 1-3, day 4-10 with levels at day 30-180 in comparison with normal controls.
Owner:THE RES FOUND OF STATE UNIV OF NEW YORK +1
Grafted protein hydrogel biological material and its preparing process
The invention relates to an aquagel material used to recover hurt nerve center. Wherein, it uses nerve center cross method to graft the layer adhesive protein (Laninin) with nerve grow activity to the molecule skeleton of transparent acid aquagel, to rpare the aquagel frame, which can accelerate the regeneration of nerve axon.
Owner:首都医科大学北京神经科学研究所
Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
InactiveUS20070161640A1Improve cognitive functionIncrease awarenessBiocideNervous disorderDiseaseMedicine
Owner:GEORGETOWN UNIV
Innate Immune Proteins As Biomarkers for CNS Injury
Owner:UNIV OF MIAMI
Protein chip used for detecting functional injury of central nervous system and manufacturing method therefor
InactiveCN101008644AHigh speedSpeed up the processMaterial analysisTOR activityBiological activation
This invention relates to one functional central neutral damage dialogue test protein chip and its process method, which comprises the following steps: using protein chip to fix multiple central neutral system damage generation development key function abnormal protein factor antigen and its array; the said protein antigen and its array abnormal protein factors act as key property protein factors in the neutral system for inflammation and activation reaction and cell ion balance adjust and signal transmission.
Owner:陈云 +3
Metabolomics profiling of central nervous system injury
A method of diagnosing central nervous system injuries such as acquired brain injury (ABI) and / or acquired spinal cord injury (ASI), including mild TBI (concussion or blast wave), mild ASI (contusion,stretch or partial cord transection), non-TBI brain injury and / or non-TSI spinal cord injury in a subject (animal or human). The method includes (a) obtaining a biological test sample from the subject, identifying metabolites in the subject's sample using metabolomics thereby obtaining a subject's metabolite matrix and generating a subject's profile using the patient's metabolite matrix; and (b)using multivariate statistical analysis and machine learning to compare the subject's profile with predetermined set of profiles of CNS injuries and a predetermined set of profiles of controls to determine if the subject has a CNS injury.
Owner:LONDON HEALTH SCI CENT RES
Human monocyte sub-population for treatment of central nervous system injury
A subpopulation of peripheral blood mononuclear cells (PBMCs) that is substantially devoid of CD3+ cells, CD19+ cells, CD56+ cells and optionally of CD16+ cells, for use in treatment of CNS injury is provided.
Owner:YEDA RES & DEV CO LTD
Gene chip for detecting functional central nerve damage and its production method
InactiveCN101008033AHigh speedSpeed up the processMicrobiological testing/measurementNerve degenerationNervous system
The invention relates to gene chip used for detecting functional central nervous damage diagnosis and the preparing method. said gene chip is equipped with oligonucleotide gene probe array, the oligonucleotide biomolecule of said probe array is the special biological gene factor playing improtant role in multiple central nervous system damage process simutaneously, relating to netural cell death and tissue necrosis, inflammation, irritated response, ion dysequilibrium inside cell, signal transmission, abnormal control of cell cycle, abnormal cell construction and nerve degeneration damage morbid physiology and molecular biology active gene, respectively. The gene chip can be used to check the conditioning way, expression level and change rule of biological factor relative to cerebral ischemia damage inside body in the beginning of clinic for high risk group of cerebral apoplexy, and to predict possibility of cerebral apoplexy; and used to conditioning way and change rule of special biological factor relative to nerve damage inside nerve cell after central nervous system damage, and relationship between cell death and disease occurancy, and provides checking criterion for cilinical treatment.
Owner:陈云 +3
Treatment for Neurological and Mental Disorders
InactiveUS20090298850A1Improve cognitive functionEfficacious for preventingOrganic active ingredientsNervous disorderEltoprazineRisk stroke
Methods for treating neurological or mental disorders in humans and the symptoms associated therewith are provided by administering eltoprazine and / or related compounds. In some embodiments, specific symptoms are treated by administering eltoprazine and / or a related compound in an effective amount to ameliorate the symptoms. Of particular significance are symptoms that are associated with cognitive dysfunction where eltoprazine will improve the symptoms and the disorder associated with that symptom. Of particular interest are non-ADHD-associated inattention, hyperactivity and impulsiveness. The methods provided herein are especially useful for improving functional recovery after CNS injury such as stroke where improved cognitive function will facilitate the acquisition of learning and memory of rehabilitative tasks.
Owner:PSYCHOGENICS
Innate immune proteins as biomarkers for CNS injury
InactiveUS20150185232A1Sugar derivativesPeptide/protein ingredientsBiomarker (petroleum)Inflammasome
The present invention provides novel markers of the severity of a central nervous system injury, such as spinal cord injury or traumatic brain injury, in a patient. In particular, protein components of inflammasomes in the cerebrospinal fluid that can be used to assess the severity of central nervous system injury in a patient are disclosed. Methods of using such protein biomarkers to determine a prognosis, direct treatment and rehabilitation efforts, and monitor response to treatment for a patient with a central nervous system injury are also described.
Owner:UNIV OF MIAMI
Along-channel and collateral-conduction guiding feedback rehabilitation training system used for lower limb potential development training
The invention discloses an along-channel and collateral-conduction guiding feedback rehabilitation training system used for lower limb potential development training and belongs to the fields of lower limb movement dysfunction caused by central nervous injury and rehabilitation training equipment. The system is characterized in that the system is a computer man-machine conversion type system which combines a traditional Chinese medicine guiding technology with channel and collateral conduction to perform central nervous potential development and lower limb movement function reconstruction. An animation technology is used for simulating the program signal curve of lower limb movement, according to the 'target-power' mechanism, an elevation movement program or a signal sequence from weak to strong of a movement muscle signal curve is set, the potential development consciousness of a patient is trained through music and image matching six-step method traditional Chinese medicine guiding training, so that a physical exercise therapist calls a training module of the lower limbs through Vista software to train the patient for actual joint movement, and damping-exertion along-channel and collateral-conduction guiding feedback rehabilitation training is achieved. A computer is used for automatically calculating elevation differences between angle and bioelectric current waveforms of the knees of a normal person and the patient when the limbs are at different positions, so that the therapy effect is improved.
Owner:国家康复辅具研究中心
Composition containing miR-124-3P and application thereof in drug for inducing neuron formation
ActiveCN109674809AShorten the timePromotes regenerative repairOrganic active ingredientsNervous disorderMir 124 3pCyclase
The invention provides a composition containing miR-124-3P and application thereof in a drug for inducing neuron formation, and belongs to the technical field of central nerve injury repairing. The composition comprises the miR-124-3P and an inducer, wherein the inducer is selected from one or several of a JAK (Janus Kinase) inhibitor, a p38-MAPK (Mitogen-activated Protein Kinase) inhibitor and anadenylate cyclase activator. The time for trans-differentiating reactive astrocyte into neurons by utilizing the composition provided by the invention is short, the steps are simple and convenient, induction components are less, and the composition is economic, effective and convenient.
Owner:JILIN UNIV
Compositions and methods for the treatment of CNS injuries
InactiveUS20080025963A1Recovery functionHigh degree of recoveryOrganic active ingredientsNervous disorderAutonomic functionMedicine
The present invention is directed to a method of improving functional recovery following a central nervous system contusion injury. The method includes administering a therapeutically effective amount of glycosaminoglycan degrading enzyme. The glycosaminoglycan degrading enzyme may be dermatan sulfate or chondroitin sulfate degrading enzymes. The central nervous system contusion injury may include a traumatic brain injury or a spinal cord injury. The functional recovery may include autonomic functions, sensory functions, motor functions or the like.
Owner:ACORDA THERAPEUTICS INC
Novel nanometer drug carrier loaded with methyllprednisolone and preparation method of novel nanometer drug carrier
ActiveCN105727306AExtended half-lifeGood slow release functionOrganic active ingredientsNervous disorderMicrosphereHalf-life
The invention discloses a novel nanometer drug carrier loaded with methyllprednisolone. The novel nanometer drug carrier comprises methyllprednisolone and a carrier, wherein the carrier is an ibuprofen modified dextran nanometer microsphere, the particle diameter of the novel nanometer drug carrier loaded with methyllprednisolone is 120 to 160 nanometers, the preparation method of the novel nanometer drug carrier loaded with methyllprednisolone comprises two steps of synthesizing the ibuprofen modified dextran nanometer microsphere and preparing novel nanoparticles loaded with methyllprednisolone. The novel nanometer drug carrier loaded with methyllprednisolone disclosed by the invention has the advantages that the nanometer microsphere synthesized by ibuprofen modified dextran is taken as the carrier, so that methyllprednisolone can be effectively and targetedly delivered to injured parts, the half-life of methylprednisolone drugs can be effectively prolonged, and methyllprednisolone and ibuprofen can play a synergistic role on promotion of central nervous system injury repair.
Owner:AFFILIATED HOSPITAL OF NANTONG UNIV
Ginseng saponin Rg1 and Rb1 in pseudo-ginseng and preparation of total saponin thereof
Owner:YUNNAN JECUI BIOTECH
Regulation of tyrosine hydroxylase by gpe
Owner:NEUREN PHARMA LTD
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com